Brief review: Glucocorticoid excretion in obesity

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 3-5, 2010, Pages 589-593

  Müssig, Karsten ^a   Remer, Thomas ^b   Maser Gluth, Christiane ^c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b RESEARCH INSTITUTE OF CHILD NUTRITION   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

11 Hydroxysteroid dehydrogenase type 1; 11 Hydroxysteroid dehydrogenase type 2; Hypothalamic pituitary adrenal axis; UFE; UFF; Urinary free cortisol; Urinary free cortisone; Urine volume

Indexed keywords

GLUCOCORTICOID;

CHRONIC STRESS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LEAN BODY WEIGHT; OBESITY; REVIEW; URINE VOLUME;

HUMANS; HYDROCORTISONE; INTRA-ABDOMINAL FAT; OBESITY; STRESS, PSYCHOLOGICAL;

EID: 77955431075     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.01.008     Document Type: Review

References (65)

1. Barness L.A., Opitz J.M., Gilbert-Barness E. Obesity: genetic, molecular, and environmental aspects. Am. J. Med. Genet. A 2007, 143A(24):3016-3034.
2. Grundy S.M. Multifactorial causation of obesity: implications for prevention. Am. J. Clin. Nutr. 1998, 67(3 Suppl.):563S-572S.
3. Dunkelman S.S., Fairhurst B., Plager J., Waterhouse C. Cortisol metabolism in obesity. J. Clin. Endocrinol. Metab. 1964, 24:832-841.
4. Purnell J.Q., Brandon D.D., Isabelle L.M., Loriaux D.L., Samuels M.H. Association of 24-h cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J. Clin. Endocrinol. Metab. 2004, 89(1):281-287.
5. Mårin P., Darin N., Amemiya T., Andersson B., Jern S., Björntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1992, 41(8):882-886.
6. Rask E., Walker B.R., Soderberg S., Livingstone D.E., Eliasson M., Johnson O., Andrew R., Olsson T. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J. Clin. Endocrinol. Metab. 2002, 87(7):3330-3336.
7. Pasquali R., Cantobelli S., Casimirri F., Capelli M., Bortoluzzi L., Flamia R., et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J. Clin. Endocrinol. Metab. 1993, 77(2):341-346.
8. Duclos M., Corcuff J.B., Etcheverry N., Rashedi M., Tabarin A., Roger P. Abdominal obesity increases overnight cortisol excretion. J. Endocrinol. Invest. 1999, 22(6):465-471.
9. Strain G.W., Zumoff B., Strain J.J., Levin J., Fukushima D.K. Cortisol production in obesity. Metabolism 1980, 29(10):980-985.
10. Björntorp P., Holm G., Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabetes Med. 1999, 16(5):373-383.
11. Dimitriou T., Maser-Gluth C., Remer T. Adrenocortical activity in healthy children is associated with fat mass. Am. J. Clin. Nutr. 2003, 77(3):731-736.
12. Strain G.W., Zumoff B., Kream J., Strain J.J., Levin J., Fukushima D. Sex difference in the influence of obesity on the 24h mean plasma concentration of cortisol. Metabolism 1982, 31(3):209-212.
13. Rubin R.T., Phillips J.J. Adrenal gland volume determination by computed tomography and magnetic resonance imaging in normal subjects. Invest. Radiol. 1991, 26(5):465-469.
14. Ludescher B., Najib A., Baar S., Machann J., Schick F., Buchkremer G., Claussen C.D., Eschweiler G.W. Increase of visceral fat and adrenal gland volume in women with depression: preliminary results of a morphometric MRI study. Int. J. Psychiatry Med. 2008, 38(3):229-240.
15. Prezio J.A., Carreon G., Clerkin E., Meloni C.R., Kyle L.H., Canary J.J. Influence of body composition on adrenal function in obesity. J. Clin. Endocrinol. Metab. 1964, 24:481-485.
16. Müssig K., Remer T., Haupt A., Gallwitz B., Fritsche A., Häring H.U., Maser-Gluth C. 11beta-Hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity. Obesity (Silver Spring) 2008, 16(6):1256-1260.
17. Remer T., Maser-Gluth C., Wudy S.A. Glucocorticoid measurements in health and disease-metabolic implications and the potential of 24-h urine analyses. Mini Rev. Med. Chem. 2008, 8(2):153-170.
18. Rask E., Olsson T., Soderberg S., Andrew R., Livingstone D.E., Johnson O., Walker B.R. Tissue-specific dysregulation of cortisol metabolism in human obesity. J. Clin. Endocrinol. Metab. 2001, 86(3):1418-1421.
19. Grossman A., Howlett T.A., Kopelman P.G. The use of CRF-41 in the differential diagnosis of Cushing's syndrome and obesity. Horm. Metab. Res. Suppl. 1987, 16:62-64.
20. Kopelman P.G., Grossman A., Lavender P., Besser G.M., Rees L.H., Coy D. The cortisol response to corticotrophin-releasing factor is blunted in obesity. Clin. Endocrinol. (Oxf.) 1988, 28(1):15-18.
21. Migeon C.J., Green O.C., Eckert J.P. Study of adrenocortical function in obesity. Metabolism 1963, 12:718-739.
22. Schteingart D.E., Gregerman R.I., Conn J.W. A comparison of the characteristics of increased adrenocortical function in obesity and in Cushing's syndrome. Metabolism 1963, 12:484-497.
23. Duclos M., Gatta B., Corcuff J.B., Rashedi M., Pehourcq F., Roger P. Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids. Clin. Endocrinol. (Oxf.) 2001, 55(4):447-454.
24. Pasquali R., Ambrosi B., Armanini D., Cavagnini F., Uberti E.D., Del Rio G., de Pergola G., Maccario M., Mantero F., Marugo M., Rotella C.M., Vettor R. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J. Clin. Endocrinol. Metab. 2002, 87(1):166-175. Study Group on Obesity of the Italian Society of Endocrinology.
25. Jessop D.S., Dallman M.F., Fleming D., Lightman S.L. Resistance to glucocorticoid feedback in obesity. J. Clin. Endocrinol. Metab. 2001, 86(9):4109-4114.
26. Chalew S.A., Lozano R.A., Armour K.M., Zadik Z., Kowarski A.A. Reduction of plasma cortisol levels in childhood obesity. J. Pediatr. 1991, 119(5):778-780.
27. Chalew S.A., Nagel H., Burt D., Edwards C.R. The integrated concentration of cortisone is reduced in obese children. J. Pediatr. Endocrinol. Metab. 1997, 10(3):287-290.
28. Fernandez-Real J.M., Pugeat M., Emptoz-Bonneton A., Ricart W. Study of the effect of changing glucose, insulin, and insulin-like growth factor-I levels on serum corticosteroid binding globulin in lean, obese, and obese subjects with glucose intolerance. Metabolism 2001, 50(10):1248-1252.
29. Stewart P.M., Boulton A., Kumar S., Clark P.M., Shackleton C.H. Cortisol metabolism in human obesity: impaired cortisone→cortisol conversion in subjects with central adiposity. J. Clin. Endocrinol. Metab. 1999, 84(3):1022-1027.
30. Tomlinson J.W., Finney J., Hughes B.A., Hughes S.V., Stewart P.M. Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss. Diabetes 2008, 57(6):1536-1543.
31. Vierhapper H., Nowotny P., Waldhäusl W. Production rates of cortisol in obesity. Obes. Res. 2004, 12(9):1421-1425.
32. Tomlinson J.W., Stewart P.M. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase. Best. Pract. Res. Clin. Endocrinol. Metab. 2001, 15(1):61-78.
33. Livingstone D.E., Jones G.C., Smith K., Jamieson P.M., Andrew R., Kenyon C.J., Walker B.R. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000, 141(2):560-563.
34. Andrew R., Phillips D.I., Walker B.R. Obesity and gender influence cortisol secretion and metabolism in man. J. Clin. Endocrinol. Metab. 1998, 83(5):1806-1809.
35. Fraser R., Ingram M.C., Anderson N.H., Morrison C., Davies E., Connell J.M. Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 1999, 33(6):1364-1368.
36. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294(5549):2166-2170.
37. Paterson J.M., Morton N.M., Fievet C., Kenyon C.J., Holmes M.C., Staels B., Seckl J.R., Mullins J.J. Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(18):7088-7093.
38. Kotelevtsev Y., Holmes M.C., Burchell A., Houston P.M., Schmoll D., Jamieson P., Best R., Brown R., Edwards C.R., Seckl J.R., Mullins J.J. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. U.S.A. 1997, 94(26):14924-14929.
39. Morton N.M., Holmes M.C., Fievet C., Staels B., Tailleux A., Mullins J.J., Seckl J.R. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J. Biol. Chem. 2001, 276(44):41293-41300.
40. Morton N.M., Paterson J.M., Masuzaki H., Holmes M.C., Staels B., Fievet C., Walker B.R., Flier J.S., Mullins J.J., Seckl J.R. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004, 53(4):931-938.
41. Paulmyer-Lacroix O., Boullu S., Oliver C., Alessi M.C., Grino M. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J. Clin. Endocrinol. Metab. 2002, 87(6):2701-2705.
42. Lindsay R.S., Wake D.J., Nair S., Bunt J., Livingstone D.E., Permana P.A., Tataranni P.A., Walker B.R. Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J. Clin. Endocrinol. Metab. 2003, 88(6):2738-2744.
43. Desbriere R., Vuaroqueaux V., Achard V., Boullu-Ciocca S., Labuhn M., Dutour A., Grino M. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity (Silver Spring) 2006, 14(5):794-798.
44. Michailidou Z., Jensen M.D., Dumesic D.A., Chapman K.E., Seckl J.R., Walker B.R., Morton N.M. Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity (Silver Spring) 2007, 15(5):1155-1163.
45. Mariniello B., Ronconi V., Rilli S., Bernante P., Boscaro M., Mantero F., Giacchetti G. Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome. Eur. J. Endocrinol. 2006, 155(3):435-441.
46. Goedecke J.H., Wake D.J., Levitt N.S., Lambert E.V., Collins M.R., Morton N.M., Andrew R., Seckl J.R., Walker B.R. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clin. Endocrinol. (Oxf.) 2006, 65(1):81-87.
47. Milagro F.I., Campion J., Martinez J.A. 11-Beta hydroxysteroid dehydrogenase type 2 expression in white adipose tissue is strongly correlated with adiposity. J. Steroid. Biochem. Mol. Biol. 2007, 104(1-2):81-84.
48. Andrews R.C., Walker B.R. Glucocorticoids and insulin resistance: old hormones, new targets. Clin. Sci. (Lond.) 1999, 96(5):513-523.
49. Bartolomucci A., Cabassi A., Govoni P., Ceresini G., Cero C., Berra D., Dadomo H., Franceschini P., Dell'Omo G., Parmigiani S., Palanza P. Metabolic consequences and vulnerability to diet-induced obesity in male mice under chronic social stress. PLoS One 2009, 4(1):e4331.
50. Shively C.A., Register T.C., Clarkson T.B. Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation. Am. J. Primatol. 2009, 71(9):742-751.
51. De Vriendt T., Moreno L.A., De Henauw S. Chronic stress and obesity in adolescents: scientific evidence and methodological issues for epidemiological research. Nutr. Metab. Cardiovasc. Dis. 2009, 19(7):511-519.
52. Cozier Y.C., Wise L.A., Palmer J.R., Rosenberg L. Perceived racism in relation to weight change in the Black women's health study. Ann. Epidemiol. 2009, 19(6):379-387.
53. Kyrou I., Tsigos C. Stress hormones: physiological stress and regulation of metabolism. Curr. Opin. Pharmacol. 2009, 9(6):787-793.
54. Vicennati V., Pasqui F., Cavazza C., Pagotto U., Pasquali R. Stress-related development of obesity and cortisol in women. Obesity (Silver Spring) 2009, 17(9):1678-1683.
55. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991, 14(12):1132-1143.
56. Fried S.K., Russell C.D., Grauso N.L., Brolin R.E. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J. Clin. Invest. 1993, 92(5):2191-2198.
57. Weigensberg M.J., Lane C.J., Winners O., Wright T., Nguyen-Rodriguez S., Goran M.I., Spruijt-Metz D. Acute effects of stress-reduction interactive guided imagery (SM) on salivary cortisol in overweight Latino adolescents. J. Altern. Complement. Med. 2009, 15(3):297-303.
58. George S.A., Khan S., Briggs H., Abelson J.L. CRH-stimulated cortisol release and food intake in healthy, non-obese adults. Psychoneuroendocrinology 2009, (Oct 12). [Epub ahead of print].
59. Bertrand P.V., Rudd B.T., Weller P.H., Day A.J. Free cortisol and creatinine in urine of healthy children. Clin. Chem. 1987, 33(11):2047-2051.
60. Mericq M.V., Cutler G.B. High fluid intake increases urine free cortisol excretion in normal subjects. J. Clin. Endocrinol. Metab. 1998, 83(2):682-684.
61. Fenske M. Urinary free cortisol and cortisone excretion in healthy individuals: influence of water loading. Steroids 2006, 71(11-12):1014-1018.
62. Shi L., Maser-Gluth C., Remer T. Daily urinary free cortisol and cortisone excretion is associated with urine volume in healthy children. Steroids 2008, 73(14):1446-1451.
63. Fenske M. Urinary free cortisol is not affected by short-term water diuresis. Clin. Chem. 1999, 45(2):316-317.
64. Putignano P., Dubini A., Cavagnini F. Urinary free cortisol is unrelated to physiological changes in urine volume in healthy women. Clin. Chem. 2000, 46(6 Pt 1):879.
65. Müssig K., Remer T., Fritsche A., Häring H.U., Maser-Gluth C. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity. Steroids 2009, 74(9):742-745.